Open AccessSurvival Benefit of Liver Transplantation for Hepatocellular Carcinoma
Author(s) -
Mounika Kanneganti,
Nadim Mahmud,
David Kaplan,
Tamar H. Taddei,
David S. Goldberg
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002816
Subject(s) - hepatocellular carcinoma , liver transplantation , medicine , transplantation , carcinoma , oncology
In the United States, nearly 30% of liver transplants (LT) are performed for hepatocellular carcinoma (HCC). Although overall long-term survival is highest with LT, there are limited data on the incremental survival benefit of LT versus other curative options (resection or ablation) due to shunting of patients towards LT.